Objective: The prostate volume is an objective due to BPH diagnosed, however it is not always concerned with the LUTS degree. LUTS is a syndrome of BOO which marked by obstructive and irritable symptoms. The ball valve mechanism in bladder neck results in increasing of BOO. The aim of this study is to prove the relation of intravesical prostatic protrussion (IPP) with prostate volume, Q max, and international prostate symptom score (IPSS) in non complicated BPH LUTS patients. Materials and method: This research is an analysis observational that involved 85 male patients aged 50 to 91 years old (average 63,98 years old) in Urology Outpatient Clinic RSUD Dr. Soetomo, starting November 2007 until April 2008. Such IPSS evaluation, prostate volume measurement, uroflowmetry examination, and IPP examination with TAUS were applied to all of these patients. Results: The calculation shows the increasing of IPP degree followed by the decreasing of Q max value, where Spearman rank correlation indicates r=-0,465 with p=0,001 (smaller than 0,05), which shows the relation between IPP and Q max. In Spearman rank correlation, with the IPP degree increasing followed by IPSS value increasing indicates r=0,456 and p=0,001, which is smaler than 0,05. Also shows the increasing of IPP degree followed by prostate volume increasing, with r=0,230 and p=0,034 is smaller than 0,05 in Spearman rank correlation. Conclusion: The research reveals a connection between IPP degree and Q max, where the higher IPP degree the lower Q max value, the higher IPP degree the bigger IPSS value, and the higher IPP degree the bigger prostate volume.
Intravesical prostatic protrussion, TRUS, Q max, IPSS
Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein A, editors. Campbell’s Urology. 8th ed. Philadelphia: Saunders; 2002. p. 1297 - 336.
Presti JC. Neoplasms of the prostate gland. In: Tanagho EA, McAninch JW, editors. Smith’s General Urology. 16th ed. New York: Lange Medical Books/Mc Graw-Hill; 2004. p. 367 – 85.
Boyle P, Liu GF. Epidemiology and Natural History. In: Chatelain C, Denis L, eds. Benign Prostat Hyperplasia. 5th ed. United Kingdom: Plymbrige; 2001. p. 19 – 61.
Terris MK. Ultrasonography and biopsy of the prostate. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein A, editors. Campbell’s Urology. 8th ed. Philadelphia: Saunders; 2002. p. 3038 – 54.
Roehrborn CG. The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy. The journal of Urology 1986; 135: 1190 – 3.
Resnick MI. Prostatic ultrasonography. In: Friedland GW, et al, editors. Uroradiology An Integrated Approach. New York: Churchill Livingstone; 1983. p. 323 – 30.
Hricak H. Evaluation of prostate size: A comparison of ultrasound and magnetic resonance imaging. J Urol Radiol. 1987; 9: 1 – 8.
Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. J Urol; 2002.
Jeong SJ, Park CS, Hwang IS, Kwak C, Cho JY, Kim SW, et al. Can intravesical prostatic protrusion predict bladder outlet obstruction? EAU; 2007.
Mc Keehan WL, Adams PS. Heparin binding growth factor/prostatropin attenuates inhibition of rat prostat tumor epithelial cell growth by transforming growth factor type beta. In Vitro Cell Dev Biol. 1988; 24: 243.